Leader in autoimmunity testing to present at upcoming investor conference. ALBUQUERQUE, NM and SAN DIEGO, CA, Nov 13, 2018 (GLOBE NEWSWIRE) – Exagen Diagnostics, a leader in autoimmune life sciences, today announced that it will present at the Piper Jaffray 30bthe Annual Healthcare Conference, which is being held Nov. 27-29 at the Lotte New York Palace in New York. Ron …
October 30, 2018 ALBUQUERQUE, NM and VISTA, CA, (GLOBE NEWSWIRE) – Exagen Diagnostics, a leader in autoimmune life sciences, today announced that President and Chief Executive Officer, Ron Rocca, will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum to be held in New York, NY at the Westin Grand Central Hotel on Thursday, November 15, 2018 at 11:30 …
Makers of the rapidly growing AVISE CTD test expands portfolio of patented CB-CAPs blood tests. ALBUQUERQUE, NM and SAN DIEGO, CA, Oct 12, 2018 (GLOBE NEWSWIRE) – Exagen Diagnostics, a leader in autoimmune life sciences, announced today that it will be updating the popular AVISE® SLE Monitor test to include levels of platelet-bound C4d (PC4d). Exagen will be the only …
Leading immunology laboratory continues strides with first ever economic impact data for AVISE Lupus. ALBUQUERQUE, NM and SAN DIEGO, CA, Oct 02, 2018 (GLOBE NEWSWIRE)– Exagen Diagostics, the exclusive providers of AVISE® testing, announced today that a total of eight scientific presentations have been accepted at this year’s 2018 ACR/ARHP Annual Meeting being held in Chicago, IL, October 19-24. …
Novel Test Now Available to Aid in Detection and Management of Widespread Debilitating Condition San Diego, CA and Albuquerque, NM, Sep 11, 2018 (GLOBE NEWSWIRE) – Exagen Diagnostics, the leader in specialty rheumatology testing, announced today availability of the first validated blood test to detect autoantibodies against carbamylated proteins (anti-CarP). Studies show that this novel test can add valuable information …
